RKVTD (Rakovina Therapeutics) ROE % Adjusted to Book Value : -51.08% (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Rakovina Therapeutics ROE % Adjusted to Book Value?

Rakovina Therapeutics's ROE % for the quarter that ended in Mar. 2025 was -259.49%. Rakovina Therapeutics's PB Ratio for the quarter that ended in Mar. 2025 was 5.08. Rakovina Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2025 was -51.08%.

Rakovina Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Rakovina Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rakovina Therapeutics ROE % Adjusted to Book Value Chart

Rakovina Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

-26.76

Rakovina Therapeutics Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
ROE % Adjusted to Book Value	Get a 7-Day Free Trial												-	-53.18	-37.27	-42.39	-51.08

Competitive Comparison of Rakovina Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Rakovina Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rakovina Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rakovina Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Rakovina Therapeutics's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Rakovina Therapeutics ROE % Adjusted to Book Value Calculation

Rakovina Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-99.53%	/	3.72
	=	-26.76%

Rakovina Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-259.49%	/	5.08
	=	-51.08%

Rakovina Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Rakovina Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Rakovina Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rakovina Therapeutics Inc (OTCPK:RKVTD) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

RKV:Canada

Address

105 1008 Beach Avenue, Vancouver, BC, CAN, V6E 1T7

Website

https://www.rakovinatherapeutics.com

Rakovina Therapeutics Inc is a biopharmaceutical research company focused on the development of cancer treatments. Its work is based on technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, it can review and optimize drug candidates at a much greater pace than ever before. The company has established a pipeline of distinctive DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners.